Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Former patient tells subcommittee long psychiatric drug regimens can cause lasting harm; urges federal tapering guidance
Summary
Laura Delano, founder of the Intercompass Initiative, described 14 years of psychiatric treatment beginning in adolescence, long-term harms she attributes to polypharmacy, and argued the U.S. lacks evidence-based tapering protocols — a gap she urged the committee to address.
Laura Delano told the subcommittee she entered the mental‑health system at 13 and was diagnosed with bipolar disorder and placed on psychiatric medication. Over years her regimen expanded and, she testified, produced physical health problems, weight gain and suicidal ideation before she ultimately stopped taking medications.
"I was diagnose…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
